Clinical Trial Update: A Pilot Trial of Topical Thalidomide for the Management of Chronic Discoid Lupus Erythematosus [Phase 2]

View source ↗

Summary

This report covers a Phase 2 pilot trial of topical thalidomide for chronic discoid lupus erythematosus. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Discoid Lupus Erythematosus

Drugs mentioned

• Thalidomide (thalidomide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Discoid Lupus Erythematosus | Phase 2 | Status: COMPLETED